Institute of Good Manufacturing Practices India®

Three US FDA observations to Ipca Labs for Silvassa facility

The US FDA inspection for Silvassa facility of Ipca Labs conducted during 19-23 August 2019. It is the formulation facility of Ipca Labs.

The firms receive three US FDA observations in Form 483.

The complete response to the received observations will be shared by the company officials within the fixed time period.